PennyStockPayCheck.com Rss

Featured Posts

Chase Bank Limits Cash Withdrawals, Bans International... Before you read this report, remember to sign up to http://pennystockpaycheck.com for 100% free stock alerts Chase Bank has moved to limit cash withdrawals while banning business customers from sending...

Read more

Richemont chairman Johann Rupert to take 'grey gap... Billionaire 62-year-old to take 12 months off from Cartier and Montblanc luxury goods groupRichemont's chairman and founder Johann Rupert is to take a year off from September, leaving management of the...

Read more

Cambodia: aftermath of fatal shoe factory collapse... Workers clear rubble following the collapse of a shoe factory in Kampong Speu, Cambodia, on Thursday

Read more

Spate of recent shock departures by 50-something CEOs While the rising financial rewards of running a modern multinational have been well publicised, executive recruiters say the pressures of the job have also been ratcheted upOn approaching his 60th birthday...

Read more

UK Uncut loses legal challenge over Goldman Sachs tax... While judge agreed the deal was 'not a glorious episode in the history of the Revenue', he ruled it was not unlawfulCampaign group UK Uncut Legal Action has lost its high court challenge over the legality...

Read more

Will Google hit $1000 or is it the next Apple?

Category : Business

Although Google’s stock keeps hitting new all-time highs, it may not necessarily suffer the same fate as Apple.

Read more: Will Google hit $1000 or is it the next Apple?

Post to Twitter

Intercell AG (INRLY: OTCQX International) | Merger between Intercell and Vivalis planned to complete on May 28, 2013 – Relevant documents filed with the Commercial Court of Lyon

Category : Stocks

Vienna (Austria), Nantes (France) May 14, 2013 – Intercell AG (Intercell, VSE; “ICLL”) and Vivalis SA (Vivalis, NYSE Euronext; “VLS”) today announced that the final administrative step for closing of the proposed merger between the two companies to create Valneva SE (Valneva) has been initiated by filing of the relevant documents with the companies’ register at the Commercial Court of Lyon. This step follows the approval of the proposed merger by the extraordinary general meetings of both companies, the issuance of the pre-merger certificates by the French Commercial Register on April 3, 2013 and by the Austrian Commercial Register on April 12, 2013, and the issuance of the certificate of legality of the merger on April 17, 2013. Subject to the registration decision by the Court of Lyon, the completion of the merger is expected for May 28, 2013 and will have the following impact on shares and trading:

Automatic exchange of Intercell shares
On the expected closing date May 28, 2013, Intercell shareholders will receive 13 new ordinary shares and 13 new preferred shares of Valneva for every 40 Intercell shares (ISIN AT0000612601) that they own. The exchange of the shares will be executed automatically and without costs for shareholders. Fractional entitlements of less than one new Valneva share will be sold on the stock market and proceeds will be credited to each shareholders account free of all charges. Vivalis shares (ISIN FR0004056851) will not be affected by any share exchange and continue to exist under the new name of Valneva. The Valneva shares will be traded on both the NYSE Euronext Paris and the Vienna Stock Exchange.

Share trading on the Vienna Stock Exchange
Intercell shares will be suspended from trading on the Vienna Stock Exchange at close of business of May 21, 2013 in order to enable the settlement of all orders before the exchange into Valneva ordinary and preferred shares. Valneva ordinary shares (ISIN FR0004056851) will start trading in the Prime Market segment of the Vienna Stock Exchange on May 28, 2013 under the ticker symbol “VLA” and will continue to be listed on the regulated market of NYSE Euronext in Paris under the ticker symbol “VLS.PA”. Valneva preferred shares (ISIN FR0011472943) will start trading on May 28, 2013 on the regulated market of NYSE Euronext in Paris under ticker symbol “VLSpr.PA” and on the unregulated Third Market Segment of the Vienna Stock Exchange under the ticker symbol “VLAP”.

Visit link: Intercell AG (INRLY: OTCQX International) | Merger between Intercell and Vivalis planned to complete on May 28, 2013 – Relevant documents filed with the Commercial Court of Lyon

Post to Twitter

Individual investors rush into Apple

Category : Business

Individual investors took advantage of Apple’s recent stock slide to snap up shares of the tech giant last month, according to brokerage firm TD Ameritrade.

Go here to see the original: Individual investors rush into Apple

Post to Twitter

What is driving the stock market rally?

Category : World News

Why are investors feeling so buoyant about global stock markets?

Visit link: What is driving the stock market rally?

Post to Twitter

Sam Zell says sell

Category : Business, Stocks

Legendary investor says stock market is in state of “euphoria,” while economy is still in the dumps.

Continued here: Sam Zell says sell

Post to Twitter

Nikkei at 5-year high after best week since 2009

Category : Business, Stocks

A 3% stock rally Friday has pushed Japan’s Nikkei to its highest close in five years and the best week since the end of 2009.

See the rest here: Nikkei at 5-year high after best week since 2009

Post to Twitter

Stocks: Shorts get squeezed

Category : Stocks

The broader U.S. stock market closed in the red Thursday, but a few favorites among short sellers surged following upbeat earnings reports.

See the article here: Stocks: Shorts get squeezed

Post to Twitter

Biotie Announces Start of Clinical Study With Nepicastat (SYN117) in Cocaine Dependence

Category : Stocks, World News

TURKU, FINLAND–(Marketwired – May 10, 2013) –  BIOTIE THERAPIES CORP. STOCK EXCHANGE RELEASE 10 May 2013 at 9.00 a.m.

Read the rest here: Biotie Announces Start of Clinical Study With Nepicastat (SYN117) in Cocaine Dependence

Post to Twitter

Biotie Announces Start of Clinical Study With Nepicastat (SYN117) in Cocaine Dependence

Category : Stocks

TURKU, FINLAND–(Marketwired – May 10, 2013) –  BIOTIE THERAPIES CORP. STOCK EXCHANGE RELEASE 10 May 2013 at 9.00 a.m.

Read more from the original source: Biotie Announces Start of Clinical Study With Nepicastat (SYN117) in Cocaine Dependence

Post to Twitter

Apple picks itself up off the mat

Category : Business, Stocks

The beleaguered tech giant has seen its stock rise in the weeks since it caved and announced a record share repurchase program.

Originally posted here: Apple picks itself up off the mat

Post to Twitter